SCHEMBL4463365

SCHEMBL4463365

COc1cc(C=C(C(C)=O)C(=O)C=Cc2ccc(O)cc2)ccc1O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SNCA P37840 3/20 0.79
GLO1 Q04760 4/20 0.76
ABL1 P00519 1/20 0.76
IKBKB O14920 2/20 0.71
CHUK O15111 2/20 0.71
IKBKG Q9Y6K9 2/20 0.71
MAPT P10636 1/20 0.71
ABCB1 P08183 1/20 0.63
AKR1B1 P15121 1/20 0.63
MAOA P21397 1/20 0.63
MAOB P27338 1/20 0.63
AKT1 P31749 1/20 0.60
APP P05067 1/20 0.59
NFKB1 P19838 2/20 0.58
JUN P05412 1/20 0.58
CYP2D6 P10635 2/20 0.57
CYP1A2 P05177 1/20 0.57
ALOX5 P09917 1/20 0.57
HSD11B1 P28845 1/20 0.57
STAT3 P40763 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7194289 0.95 SNCA (0.88) SNCAGLO1ABL1IKBKBCHUK
SCHEMBL3208332 0.84 GLO1 (0.71) SNCAGLO1ABL1IKBKBCHUK
SCHEMBL3208354 0.84 GLO1 (0.71) SNCAGLO1ABL1IKBKBCHUK
SCHEMBL3208339 0.84 GLO1 (0.71) SNCAGLO1ABL1IKBKBCHUK
SCHEMBL7523992 0.84 MAPT (1.00) SNCAGLO1ABL1IKBKBCHUK
SCHEMBL23817770 0.83 GLO1 (1.00) SNCAGLO1ABL1IKBKBCHUK
SCHEMBL7585369 0.83 GLO1 (0.87) SNCAGLO1ABL1IKBKBCHUK
SCHEMBL30497483 0.83 GLO1 (0.87) SNCAGLO1ABL1IKBKBCHUK
SCHEMBL29449976 0.83 GLO1 (1.00) SNCAGLO1ABL1IKBKBCHUK
SCHEMBL12394170 0.80 MAPT (0.85) SNCAGLO1ABL1IKBKBCHUK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7507864-B2 Method for the synthesis of curcumin analogues SALISBURY UNIVERSITY (US) 2009-03-24 US disclosed
US-20080033055-A1 Method for the Synthesis of Curcumin Analogues SALISBURY UNIVERSITY 2008-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080033055-A1 Method for the Synthesis of Curcumin Analogues APP, PSEN1, SQLE SNCA 73/4885GLO1 341/4885ABL1 3795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.